Gregor Diagnostics reported raising $4.4 Million in an initial SEC Form D filing, from an offering of $6 Million
PRIVATEOct 31, 2023Late filing, first sale Mar 30, 2023 Amount Raised
$4.4 Million
$4.4 Million sold, per
SEC Form D (first sale Mar 30, 2023)
DallasBiotechnologyWho to call at Gregor Diagnostics, and when
A new round usually means Gregor Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gregor Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gregor Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gregor Diagnostics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★ 4.8/5 on G2
Location
5910 N. Central Expressway
Dallas, Texas, United States
About
Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gregor Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Gregor Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.
